| 000 | 01047nam a22003017a 4500 | ||
|---|---|---|---|
| 001 | D0001B003659 | ||
| 003 | DOH | ||
| 005 | 20210128140650.0 | ||
| 008 | 210128b ||||| |||| 00| 0 eng d | ||
| 020 | _a9789241209984 | ||
| 040 | _erda | ||
| 245 | 0 | 0 |
_aWHO Expert Committee on Drug Dependence : _bthirty-seventh report |
| 260 |
_aGeneva : _bWHO, _c2016. |
||
| 300 | _a34 pages. | ||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 490 |
_aWHO technical report series ; _v 998 |
||
| 650 | 2 |
_aPsychotropic Drugs _xclassification |
|
| 650 | 2 | _aDrug Evaluation | |
| 650 | 2 | _aDrug and Narcotic Control | |
| 650 | 2 |
_aDrugs, Essential _xsupply and distribution |
|
| 650 | 2 | _aInternational Cooperation | |
| 710 | 2 | _aWorld Health Organization | |
| 711 | 2 |
_aWHO Expert Committee on Drug Dependence. Meeting _n(37th : _d2015 : _cGeneva, Switzerland) |
|
| 856 | _uhttps://apps.who.int/iris/bitstream/handle/10665/206452/WHO_TRS_998_eng.pdf?sequence=1&isAllowed=y | ||
| 942 |
_2nlm _cBK |
||
| 999 |
_c2553 _d2553 |
||